Targeting mechanisms of Pseudomonas aeruginosa pathogenesis

被引:243
作者
Kipnis, E [1 ]
Sawa, T [1 ]
Wiener-Kronish, J [1 ]
机构
[1] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA
来源
MEDECINE ET MALADIES INFECTIEUSES | 2006年 / 36卷 / 02期
关键词
Pseudomonas aeruginosa; pathogenicity; virulence factors;
D O I
10.1016/j.medmal.2005.10.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pseudomonas aeruginosa is an opportunistic pathogen responsible for ventilator-acquired pneumonia, acute lower respiratory tract infections in immunocompromised patients and chronic respiratory infections in cystic fibrosis patients. High incidence, infection severity and increasing resistance characterize P. aeruginosa infections, highlighting the need for new therapeutic options. One such option is to target the many pathogenic mechanisms conferred to P. aeruginosa by its large genome encoding many different virulence factors. This article reviews the pathogenic mechanisms and potential therapies targeting these mechanisms in P. aeruginosa respiratory infections. (c) 2006 Elsevier SAS. All rights reserved.
引用
收藏
页码:78 / 91
页数:14
相关论文
共 172 条
[81]   Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia [J].
Kurahashi, K ;
Kajikawa, O ;
Sawa, T ;
Ohara, M ;
Gropper, MA ;
Frank, DW ;
Martin, TR ;
Wiener-Kronish, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :743-750
[82]   Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes [J].
Lai, ZZ ;
Kimmel, R ;
Petersen, S ;
Thomas, S ;
Pier, G ;
Bezabeh, B ;
Luo, R ;
Schreiber, JR .
VACCINE, 2005, 23 (25) :3264-3271
[83]   Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa [J].
Lamont, IL ;
Beare, PA ;
Ochsner, U ;
Vasil, AI ;
Vasil, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :7072-7077
[84]   INHIBITION OF BACTERIAL MOTILITY WITH HUMAN ANTIFLAGELLAR MONOCLONAL-ANTIBODIES ATTENUATES PSEUDOMONAS AERUGINOSA-INDUCED PNEUMONIA IN THE IMMUNOCOMPETENT RAT [J].
LANDSPERGER, WJ ;
KELLYWINTENBERG, KD ;
MONTIE, TC ;
KNIGHT, LS ;
HANSEN, MB ;
HUNTENBURG, CC ;
SCHNEIDKRAUT, MJ .
INFECTION AND IMMUNITY, 1994, 62 (11) :4825-4830
[85]   Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients [J].
Lang, AB ;
Horn, MP ;
Imboden, MA ;
Zuercher, AW .
VACCINE, 2004, 22 :S44-S48
[86]   Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection [J].
Lang, AB ;
Rüdeberg, A ;
Schöni, MH ;
Que, JU ;
Fürer, E ;
Schaad, UB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) :504-510
[87]   The role of pyocyanin in Pseudomonas aeruginosa infection [J].
Lau, GW ;
Hassett, DJ ;
Ran, HM ;
Kong, FS .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (12) :599-606
[88]   Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice [J].
Lau, GW ;
Ran, HM ;
Kong, FS ;
Hassett, DJ ;
Mavrodi, D .
INFECTION AND IMMUNITY, 2004, 72 (07) :4275-4278
[89]   Activities of pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during infection [J].
Lee, VT ;
Smith, RS ;
Tümmler, B ;
Lory, S .
INFECTION AND IMMUNITY, 2005, 73 (03) :1695-1705
[90]   Small molecular weight secretory factors from Pseudomonas aeruginosa have opposite effects on IL-8 and RANTES expression by human airway epithelial cells [J].
Leidal, KG ;
Munson, KL ;
Denning, GM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (02) :186-195